Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma.
Mansour AM, Arevalo JF, Al Kahtani E, Zegarra H, Abboud E, Anand R, Ahmadieh H, Sisk RA, Mirza S, Tuncer S, Navea Tejerina A, Mataix J, Ascaso FJ, Pulido JS, Guthoff R, Goebel W, Roh YJ, Banker AS, Gentile RC, Martinez IA, Morris R, Panday N, Min PJ, Mercé E, Lai TY, Massoud V, Ghazi NG. Mansour AM, et al. Among authors: banker as. J Ophthalmol. 2014;2014:210458. doi: 10.1155/2014/210458. Epub 2014 Jul 23. J Ophthalmol. 2014. PMID: 25147732 Free PMC article.
Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).
Nguyen QD, Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S, Rathinam SR, Thurau S, Abraham A, Wilson L, Yang Y, Shams N; Sirolimus study Assessing double-masKed Uveitis tReAtment (SAKURA) Study Group. Nguyen QD, et al. Among authors: banker as. Ophthalmology. 2016 Nov;123(11):2413-2423. doi: 10.1016/j.ophtha.2016.07.029. Epub 2016 Sep 28. Ophthalmology. 2016. PMID: 27692526 Free article. Clinical Trial.
Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant.
Busch C, Rehak M, Sarvariya C, Zur D, Iglicki M, Lima LH, Invernizzi A, Viola F, Agrawal K, Sinawat S, Couturier A, Mehta A, Juneja R, Jain H, Agarwal AK, Goel N, Nagpal M, Gupta V, Banker A, Loewenstein A, Okada M, Saatci AO, Mansour AM, Chhablani J. Busch C, et al. Among authors: banker a. Br J Ophthalmol. 2019 Apr;103(4):463-468. doi: 10.1136/bjophthalmol-2017-311805. Epub 2018 Jun 11. Br J Ophthalmol. 2019. PMID: 29891733
Safety of 5914 intravitreal ziv-aflibercept injections.
Singh SR, Stewart MW, Chattannavar G, Ashraf M, Souka A, ElDardeery M, Wadhwa N, Sarvaiya C, Mansour AM, Marashi A, Ramchandani S, Braimah IZ, Jabbarpoor Bonyadi MH, Ramezani A, Soheilian M, de Oliveira Dias JR, de Andrade GC, Maia A, Rodrigues EB, Farah ME, Banker A, Chhablani J; Ziv-aflibercept Study Group. Singh SR, et al. Among authors: banker a. Br J Ophthalmol. 2019 Jun;103(6):805-810. doi: 10.1136/bjophthalmol-2018-312453. Epub 2018 Aug 11. Br J Ophthalmol. 2019. PMID: 30099379
Safety of 6000 intravitreal dexamethasone implants.
Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group. Rajesh B, et al. Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30. Br J Ophthalmol. 2020. PMID: 31040132
107 results